Goat Anti-NR5A2 / LRH1 (aa328-338) Antibody

Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.

100 µg

Aliquot and store at -20°C. Minimize freezing and thawing.

nuclear receptor subfamily 5 group A member 2|nuclear receptor NR5A2|liver receptor homolog-1|liver receptor homolog 1|liver nuclear receptor homolog-1 variant 2|hepatocytic transcription factor|fetoprotein-alpha 1 (AFP) transcription factor|b1-binding factor, hepatocyte transcription factor which activates enhancer II of hepatitis B virus|alpha-1-fetoprotein transcription factor|CYP7A promoter-binding factor|hB1F-2|LRH1|LRH-1|FTZ-F1beta|FTZ-F1|FTF|CPF|B1F2|B1F|nuclear receptor subfamily 5, group A, member 2|NR5A2

NP_995582.1; NP_003813.1

EBP12284

Peptide with sequence C-QEQANRSKHEK, from the internal region of the protein sequence according to NP_995582.1; NP_003813.1.

This antibody is expected to recognize both reported isoforms (NP_995582.1; NP_003813.1).

C-QEQANRSKHEK

Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Refrigerated

Human

Human

2494

Paraffin embedded Human Placenta. Recommended concentration: 5µg/ml.

Antibody detection limit dilution 1:128000.

Approx 55kDa band observed in lysates of cell line HepG2 (calculated MW of 56.5kDa according to NP_003813.1). Recommended concentration: 1-3µg/ml. Primary incubation was 1 hour.

Pep-ELISA, WB, IHC